Medical Communications

Takeda acquired Ariad Pharmaceuticals at the beginning on the year for $5.2 billion, a price many thought was relatively high …

It’s the end of the week, and the headlines were populated with stand-out stories that proved popular with our readers. …

Sanofi and Regeneron’s Dupixent (dupilumab) has become the first biologic medicine to be approved by the FDA for the treatment …

AstraZeneca has ended the month with more positive news on Tagrisso, that had previously been approved in China under its …

Key drug discovery investment trends

The cross-Atlantic partnership CARB-X, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, has announced that it would be funding 11 biotech companies …

Takeda has named Giles Platford as its new President of Europe and Canada (EUCAN) Business Unit as of 1 April, …

Paul Catchpole, Value and Access Director at the Association of the British Pharmaceutical Industry (ABPI), gives his thoughts on the …

After much speculation, Donald Trump recently announced his top pick for Commissioner of the FDA as Dr Scott Gottlieb. Gottlieb …

A new report, entitled Women on NHS board: 50:50 by 2020, found that women occupied only 41% of board positions …

From industry reaction to NICE’s new regulatory guidelines to the rising threat of counterfeit medicine, you can read all the …

NHS England has identified 10 items that it believes can cut £128 million from its yearly bill. The 10 items …

Alexion had been left in leadership limbo for the beginning of the year, as former CEO and CFO left under …

Kite Pharma has revealed the addition of celebrated bioscientist and researcher Dr Owen N. Witte to its Board of Directors, …

The research organisation ABPI, alongside RAND Europe, has released a ‘snapshot’ of data, from its Disclosure UK database, from January …